{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:54:37Z","timestamp":1790942077621,"version":"4.1.0"},"reference-count":152,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100006108","name":"U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["R21TR001739"],"award-info":[{"award-number":["R21TR001739"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["U34TR003594"],"award-info":[{"award-number":["U34TR003594"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77443-x","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:04:26Z","timestamp":1788336266000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gene regulatory network analysis identifies auranofin as an anti-atherosclerotic drug"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1125-4631","authenticated-orcid":false,"given":"Letizia","family":"Amadori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Calcagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravneet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9971-1800","authenticated-orcid":false,"given":"Hauke","family":"Horstmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9752-1256","authenticated-orcid":false,"given":"Tianshe","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gildea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peik Sean","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roza","family":"Shamailova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonum","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3302-3658","authenticated-orcid":false,"given":"Christopher A.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swathy","family":"Sajja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5986-1807","authenticated-orcid":false,"given":"Jordan","family":"Bresciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1794-0413","authenticated-orcid":false,"given":"Maxwell","family":"La Forest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam A.","family":"Ghotbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Faries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9802-143X","authenticated-orcid":false,"given":"Edward A.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3439-7347","authenticated-orcid":false,"given":"Zahi A.","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8058-3423","authenticated-orcid":false,"given":"Nathanael R.","family":"Fillmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0993-9909","authenticated-orcid":false,"given":"Jaime","family":"Ramos-Cejudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4353-9965","authenticated-orcid":false,"given":"Benjamin","family":"Readhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel T.","family":"Dudley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1945-7425","authenticated-orcid":false,"given":"Johan L. M.","family":"Bjorkegren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2473-6058","authenticated-orcid":false,"given":"Chiara","family":"Giannarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"77443_CR1","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1161\/CIR.0000000000001412","volume":"153","author":"LP Palaniappan","year":"2026","unstructured":"Palaniappan, L. P. et al. 2026 Heart Disease and stroke statistics: a report of US and Global Data From the American Heart Association. Circulation 153, e275\u2013e906 (2026).","journal-title":"Circulation"},{"key":"77443_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.gheart.2014.01.008","volume":"9","author":"GA Mensah","year":"2014","unstructured":"Mensah, G. A., Moran, A. E., Roth, G. A. & Narula, J. The global burden of cardiovascular diseases, 1990-2010. Glob. Heart 9, 183\u2013184 (2014).","journal-title":"Glob. Heart"},{"key":"77443_CR3","doi-asserted-by":"crossref","unstructured":"Cholesterol Treatment et al. Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. PLoS ONE 7, e29849 (2012).","DOI":"10.1371\/journal.pone.0029849"},{"key":"77443_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","volume":"380","author":"C Cholesterol Treatment Trialists","year":"2012","unstructured":"Cholesterol Treatment Trialists, C. et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 380, 581\u2013590 (2012).","journal-title":"Lancet"},{"key":"77443_CR5","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.jacc.2025.08.047","volume":"87","author":"GA Mensah","year":"2026","unstructured":"Mensah, G. A., Arnold, N., Prabhu, S. D., Ridker, P. M. & Welty, F. K. Inflammation and cardiovascular disease: 2025 ACC scientific statement: a report of the American College of Cardiology. J. Am. Coll. Cardiol. 87, 1381\u20131404 (2026).","journal-title":"J. Am. Coll. Cardiol."},{"key":"77443_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng.2480","volume":"45","author":"CAD Consortium","year":"2013","unstructured":"Consortium, C. A. D. et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat. Genet. 45, 25\u201333 (2013).","journal-title":"Nat. Genet."},{"key":"77443_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ng.784","volume":"43","author":"H Schunkert","year":"2011","unstructured":"Schunkert, H. et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet 43, 333\u2013338 (2011).","journal-title":"Nat. Genet"},{"key":"77443_CR8","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.jacbts.2021.04.001","volume":"6","author":"T Kessler","year":"2021","unstructured":"Kessler, T. & Schunkert, H. Coronary artery disease genetics enlightened by genome-wide association studies. JACC Basic Transl. Sci. 6, 610\u2013623 (2021).","journal-title":"JACC Basic Transl. Sci."},{"key":"77443_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fcvm.2018.00072","volume":"5","author":"AW Turner","year":"2018","unstructured":"Turner, A. W., Wong, D., Dreisbach, C. N. & Miller, C. L. GWAS reveal targets in vessel wall pathways to treat coronary artery disease. Front. Cardiovasc. Med. 5, 72 (2018).","journal-title":"Front. Cardiovasc. Med."},{"key":"77443_CR10","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1038\/s41591-022-01891-3","volume":"28","author":"C Tcheandjieu","year":"2022","unstructured":"Tcheandjieu, C. et al. Large-scale genome-wide association study of coronary artery disease in genetically diverse populations. Nat. Med. 28, 1679\u20131692 (2022).","journal-title":"Nat. Med."},{"key":"77443_CR11","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jacc.2014.12.033","volume":"65","author":"JLM Bjorkegren","year":"2015","unstructured":"Bjorkegren, J. L. M., Kovacic, J. C., Dudley, J. T. & Schadt, E. E. Genome-wide significant loci: How important are they? Systems genetics to understand heritability of coronary artery disease and other common complex disorders. J. Am. Coll. Cardiol. 65, 830\u2013845 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"77443_CR12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nature08454","volume":"461","author":"EE Schadt","year":"2009","unstructured":"Schadt, E. E. Molecular networks as sensors and drivers of common human diseases. Nature 461, 218\u2013223 (2009).","journal-title":"Nature"},{"key":"77443_CR13","doi-asserted-by":"publisher","first-page":"115rv111","DOI":"10.1126\/scitranslmed.3002132","volume":"4","author":"EE Schadt","year":"2012","unstructured":"Schadt, E. E. & Bjorkegren, J. L. NEW: network-enabled wisdom in biology, medicine, and health care. Sci. Transl. Med. 4, 115rv111 (2012).","journal-title":"Sci. Transl. Med."},{"key":"77443_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1161\/CIRCGENETICS.114.000640","volume":"8","author":"H Foroughi Asl","year":"2015","unstructured":"Foroughi Asl, H. et al. Expression quantitative trait Loci acting across multiple tissues are enriched in inherited risk for coronary artery disease. Circ. Cardiovasc. Genet. 8, 305\u2013315 (2015).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"77443_CR15","doi-asserted-by":"publisher","first-page":"e1004201","DOI":"10.1371\/journal.pgen.1004201","volume":"10","author":"JL Bjorkegren","year":"2014","unstructured":"Bjorkegren, J. L. et al. Plasma cholesterol-induced lesion networks activated before regression of early, mature, and advanced atherosclerosis. PLoS Genet. 10, e1004201 (2014).","journal-title":"PLoS Genet."},{"key":"77443_CR16","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1161\/ATVBAHA.115.306108","volume":"35","author":"I Braenne","year":"2015","unstructured":"Braenne, I. et al. Prediction of causal candidate genes in coronary artery disease loci. Arterioscler Thromb. Vasc. Biol. 35, 2207\u20132217 (2015).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"77443_CR17","doi-asserted-by":"publisher","first-page":"e1000754","DOI":"10.1371\/journal.pgen.1000754","volume":"5","author":"S Hagg","year":"2009","unstructured":"Hagg, S. et al. Multi-organ expression profiling uncovers a gene module in coronary artery disease involving transendothelial migration of leukocytes and LIM domain binding 2: the Stockholm Atherosclerosis Gene Expression (STAGE) study. PLoS Genet. 5, e1000754 (2009).","journal-title":"PLoS Genet."},{"key":"77443_CR18","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1161\/ATVBAHA.113.302709","volume":"34","author":"MM Shang","year":"2014","unstructured":"Shang, M. M. et al. Lim domain binding 2: a key driver of transendothelial migration of leukocytes and atherosclerosis. Arterioscler Thromb. Vasc. Biol. 34, 2068\u20132077 (2014).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"77443_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/gm328","volume":"4","author":"BE Stranger","year":"2012","unstructured":"Stranger, B. E., Bjorkegren, J., Dolan, M. E. & Ritchie, M. D. Systems and genome-wide approaches unite to provide a route to personalized medicine. Genome Med. 4, 29 (2012).","journal-title":"Genome Med."},{"key":"77443_CR20","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1126\/science.aad6970","volume":"353","author":"O Franzen","year":"2016","unstructured":"Franzen, O. et al. Cardiometabolic risk loci share downstream cis- and trans-gene regulation across tissues and diseases. Science 353, 827\u2013830 (2016).","journal-title":"Science"},{"key":"77443_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s44161-021-00009-1","volume":"1","author":"S Koplev","year":"2022","unstructured":"Koplev, S. et al. A mechanistic framework for cardiometabolic and coronary artery diseases. Nat. Cardiovasc. Res. 1, 85\u2013100 (2022).","journal-title":"Nat. Cardiovasc. Res."},{"key":"77443_CR22","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s44161-023-00278-y","volume":"2","author":"L Amadori","year":"2023","unstructured":"Amadori, L. et al. Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis. Nat. Cardiovasc. Res. 2, 550\u2013571 (2023).","journal-title":"Nat. Cardiovasc. Res."},{"key":"77443_CR23","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cels.2016.02.002","volume":"2","author":"HA Talukdar","year":"2016","unstructured":"Talukdar, H. A. et al. Cross-tissue regulatory gene networks in coronary artery disease. Cell Syst. 2, 196\u2013208 (2016).","journal-title":"Cell Syst."},{"key":"77443_CR24","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/ng.3396","volume":"47","author":"M Nikpay","year":"2015","unstructured":"Nikpay, M. et al. A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat. Genet. 47, 1121\u20131130 (2015).","journal-title":"Nat. Genet."},{"key":"77443_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1101\/gr.099234.109","volume":"20","author":"BJ Bennett","year":"2010","unstructured":"Bennett, B. J. et al. A high-resolution association mapping panel for the dissection of complex traits in mice. Genome Res. 20, 281\u2013290 (2010).","journal-title":"Genome Res."},{"key":"77443_CR26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/BF00914097","volume":"14","author":"H Friedman","year":"1990","unstructured":"Friedman, H. et al. Auranofin-induced suppression of autoimmune antibody production and inflammation in genetically autoimmune-prone mice. Inflammation 14, 463\u2013470 (1990).","journal-title":"Inflammation"},{"key":"77443_CR27","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/0192-0561(86)90091-3","volume":"8","author":"T Fujitsu","year":"1986","unstructured":"Fujitsu, T. et al. Effect of auranofin on autoimmune disease in a mouse model. Int. J. Immunopharmacol. 8, 897\u2013910 (1986).","journal-title":"Int. J. Immunopharmacol."},{"key":"77443_CR28","first-page":"CD002048","volume":"2000","author":"ME Suarez-Almazor","year":"2000","unstructured":"Suarez-Almazor, M. E., Spooner, C. H., Belseck, E. & Shea, B. Auranofin versus placebo in rheumatoid arthritis. Cochrane Database Syst. Rev. 2000, CD002048 (2000).","journal-title":"Cochrane Database Syst. Rev."},{"key":"77443_CR29","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb, J. et al. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929\u20131935 (2006).","journal-title":"Science"},{"key":"77443_CR30","first-page":"1437","volume":"171","author":"A Subramanian","year":"2017","unstructured":"Subramanian, A. et al. A next generation connectivity map: L1000 platform and the first 1,000,000. Profiles Cell 171, 1437\u20131452 e1417 (2017).","journal-title":"Profiles Cell"},{"key":"77443_CR31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ejphar.2015.11.032","volume":"769","author":"LY Bai","year":"2015","unstructured":"Bai, L. Y. et al. BX795, a TBK1 inhibitor, exhibits antitumor activity in human oral squamous cell carcinoma through apoptosis induction and mitotic phase arrest. Eur. J. Pharm. 769, 287\u2013296 (2015).","journal-title":"Eur. J. Pharm."},{"key":"77443_CR32","doi-asserted-by":"publisher","first-page":"101272","DOI":"10.1016\/j.tranon.2021.101272","volume":"15","author":"R Chilamakuri","year":"2022","unstructured":"Chilamakuri, R. et al. BX-795 inhibits neuroblastoma growth and enhances sensitivity towards chemotherapy. Transl. Oncol. 15, 101272 (2022).","journal-title":"Transl. Oncol."},{"key":"77443_CR33","doi-asserted-by":"publisher","first-page":"14136","DOI":"10.1074\/jbc.M109.000414","volume":"284","author":"K Clark","year":"2009","unstructured":"Clark, K., Plater, L., Peggie, M. & Cohen, P. Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation. J. Biol. Chem. 284, 14136\u201314146 (2009).","journal-title":"J. Biol. Chem."},{"key":"77443_CR34","doi-asserted-by":"publisher","first-page":"19867","DOI":"10.1074\/jbc.M501367200","volume":"280","author":"RI Feldman","year":"2005","unstructured":"Feldman, R. I. et al. Novel small molecule inhibitors of 3-phosphoinositide-dependent kinase-1. J. Biol. Chem. 280, 19867\u201319874 (2005).","journal-title":"J. Biol. Chem."},{"key":"77443_CR35","doi-asserted-by":"publisher","first-page":"1094694","DOI":"10.3389\/fimmu.2023.1094694","volume":"14","author":"PA Tauber","year":"2023","unstructured":"Tauber, P. A. et al. The small molecule inhibitor BX-795 uncouples IL-2 production from inhibition of Th2 inflammation and induces CD4(+) T cells resembling iTreg. Front. Immunol. 14, 1094694 (2023).","journal-title":"Front. Immunol."},{"key":"77443_CR36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00210-017-1343-x","volume":"390","author":"NT Abdali","year":"2017","unstructured":"Abdali, N. T., Yaseen, A. H., Said, E. & Ibrahim, T. M. Rho kinase inhibitor fasudil mitigates high-cholesterol diet-induced hypercholesterolemia and vascular damage. Naunyn Schmiedebergs Arch. Pharm. 390, 409\u2013422 (2017).","journal-title":"Naunyn Schmiedebergs Arch. Pharm."},{"key":"77443_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1475-2840-11-65","volume":"11","author":"H Li","year":"2012","unstructured":"Li, H. et al. ROCK inhibitor fasudil attenuated high glucose-induced MCP-1 and VCAM-1 expression and monocyte-endothelial cell adhesion. Cardiovasc. Diabetol. 11, 65 (2012).","journal-title":"Cardiovasc. Diabetol."},{"key":"77443_CR38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.atherosclerosis.2009.04.025","volume":"207","author":"DJ Wu","year":"2009","unstructured":"Wu, D. J. et al. Effects of fasudil on early atherosclerotic plaque formation and established lesion progression in apolipoprotein E-knockout mice. Atherosclerosis 207, 68\u201373 (2009).","journal-title":"Atherosclerosis"},{"key":"77443_CR39","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1158\/1535-7163.MCT-05-0440","volume":"5","author":"H Ying","year":"2006","unstructured":"Ying, H. et al. The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models. Mol. Cancer Ther. 5, 2158\u20132164 (2006).","journal-title":"Mol. Cancer Ther."},{"key":"77443_CR40","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.2165\/00003495-200666130-00010","volume":"66","author":"MP Curran","year":"2006","unstructured":"Curran, M. P., Robinson, D. M. & Keating, G. M. Intravenous nicardipine: its use in the short-term treatment of hypertension and various other indications. Drugs 66, 1755\u20131782 (2006).","journal-title":"Drugs"},{"key":"77443_CR41","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1177\/106002809002400612","volume":"24","author":"BR Goldspiel","year":"1990","unstructured":"Goldspiel, B. R. & Kohler, D. R. Flutamide: an antiandrogen for advanced prostate cancer. DICP 24, 616\u2013623 (1990).","journal-title":"DICP"},{"key":"77443_CR42","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s00109-003-0449-4","volume":"81","author":"R Iliescu","year":"2003","unstructured":"Iliescu, R. et al. Androgen receptor independent cardiovascular action of the antiandrogen flutamide. J. Mol. Med. 81, 420\u2013427 (2003).","journal-title":"J. Mol. Med."},{"key":"77443_CR43","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1111\/bcp.16176","volume":"90","author":"S Xiao","year":"2024","unstructured":"Xiao, S. et al. Efficacy and safety of androgen receptor inhibitors for treatment of advanced prostate cancer: a systematic review and network meta-analysis. Br. J. Clin. Pharm. 90, 2067\u20132078 (2024).","journal-title":"Br. J. Clin. Pharm."},{"key":"77443_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27903-2","volume":"8","author":"KM Cahill","year":"2018","unstructured":"Cahill, K. M., Huo, Z., Tseng, G. C., Logan, R. W. & Seney, M. L. Improved identification of concordant and discordant gene expression signatures using an updated rank-rank hypergeometric overlap approach. Sci. Rep. 8, 9588 (2018).","journal-title":"Sci. Rep."},{"key":"77443_CR45","doi-asserted-by":"publisher","first-page":"e169","DOI":"10.1093\/nar\/gkq636","volume":"38","author":"SB Plaisier","year":"2010","unstructured":"Plaisier, S. B., Taschereau, R., Wong, J. A. & Graeber, T. G. Rank-rank hypergeometric overlap: identification of statistically significant overlap between gene-expression signatures. Nucleic Acids Res. 38, e169 (2010).","journal-title":"Nucleic Acids Res."},{"key":"77443_CR46","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1194\/jlr.R400010-JLR200","volume":"45","author":"AC Li","year":"2004","unstructured":"Li, A. C. & Glass, C. K. PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis. J. Lipid Res. 45, 2161\u20132173 (2004).","journal-title":"J. Lipid Res."},{"key":"77443_CR47","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1093\/cvr\/cvz338","volume":"116","author":"C Mineo","year":"2020","unstructured":"Mineo, C. Lipoprotein receptor signalling in atherosclerosis. Cardiovasc. Res. 116, 1254\u20131274 (2020).","journal-title":"Cardiovasc. Res."},{"key":"77443_CR48","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1172\/JCI30485","volume":"117","author":"B Zhao","year":"2007","unstructured":"Zhao, B. et al. Macrophage-specific transgenic expression of cholesteryl ester hydrolase significantly reduces atherosclerosis and lesion necrosis in Ldlr mice. J. Clin. Investig. 117, 2983\u20132992 (2007).","journal-title":"J. Clin. Investig."},{"key":"77443_CR49","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1161\/CIRCULATIONAHA.121.058615","volume":"146","author":"CP Manta","year":"2022","unstructured":"Manta, C. P. et al. Targeting of scavenger receptors stabilin-1 and stabilin-2 ameliorates atherosclerosis by a plasma proteome switch mediating monocyte\/macrophage suppression. Circulation 146, 1783\u20131799 (2022).","journal-title":"Circulation"},{"key":"77443_CR50","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1161\/CIRCULATIONAHA.118.036044","volume":"139","author":"Q Fan","year":"2019","unstructured":"Fan, Q. et al. Dectin-1 contributes to myocardial ischemia\/reperfusion injury by regulating macrophage polarization and neutrophil infiltration. Circulation 139, 663\u2013678 (2019).","journal-title":"Circulation"},{"key":"77443_CR51","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cca.2013.11.026","volume":"429","author":"XH Yu","year":"2014","unstructured":"Yu, X. H. et al. NPC1, intracellular cholesterol trafficking and atherosclerosis. Clin. Chim. Acta 429, 69\u201375 (2014).","journal-title":"Clin. Chim. Acta"},{"key":"77443_CR52","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.metabol.2015.06.001","volume":"64","author":"HJ Hwang","year":"2015","unstructured":"Hwang, H. J. et al. LECT2 induces atherosclerotic inflammatory reaction via CD209 receptor-mediated JNK phosphorylation in human endothelial cells. Metabolism 64, 1175\u20131182 (2015).","journal-title":"Metabolism"},{"key":"77443_CR53","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/s44161-023-00354-3","volume":"2","author":"MT Patterson","year":"2023","unstructured":"Patterson, M. T. et al. TREM2 promotes foamy macrophage lipid uptake and survival in atherosclerosis. Nat. Cardiovasc. Res. 2, 1015\u20131031 (2023).","journal-title":"Nat. Cardiovasc. Res."},{"key":"77443_CR54","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s44161-024-00429-9","volume":"3","author":"M Piollet","year":"2024","unstructured":"Piollet, M. et al. TREM2 protects from atherosclerosis by limiting necrotic core formation. Nat. Cardiovasc Res 3, 269\u2013282 (2024).","journal-title":"Nat. Cardiovasc Res"},{"key":"77443_CR55","doi-asserted-by":"publisher","first-page":"101386","DOI":"10.1016\/j.tranon.2022.101386","volume":"19","author":"S Calhoun","year":"2022","unstructured":"Calhoun, S., Duan, L. & Maki, C. G. Acetyl-CoA synthetases ACSS1 and ACSS2 are 4-hydroxytamoxifen responsive factors that promote survival in tamoxifen treated and estrogen deprived cells. Transl. Oncol. 19, 101386 (2022).","journal-title":"Transl. Oncol."},{"key":"77443_CR56","doi-asserted-by":"crossref","unstructured":"E,G. et al. Enhanced BPGM\/2,3-DPG pathway activity suppresses glycolysis in hypoxic astrocytes via FIH-1 and TET2. Brain Res. Bull 192, 36\u201346 (2023).","DOI":"10.1016\/j.brainresbull.2022.11.002"},{"key":"77443_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45803-x","volume":"9","author":"I Zwarts","year":"2019","unstructured":"Zwarts, I. et al. Identification of the fructose transporter GLUT5 (SLC2A5) as a novel target of nuclear receptor LXR. Sci. Rep. 9, 9299 (2019).","journal-title":"Sci. Rep."},{"key":"77443_CR58","doi-asserted-by":"publisher","first-page":"1268308","DOI":"10.3389\/fendo.2023.1268308","volume":"14","author":"N Rabbani","year":"2023","unstructured":"Rabbani, N. & Thornalley, P. J. Hexokinase-linked glycolytic overload and unscheduled glycolysis in hyperglycemia-induced pathogenesis of insulin resistance, beta-cell glucotoxicity, and diabetic vascular complications. Front. Endocrinol. 14, 1268308 (2023).","journal-title":"Front. Endocrinol."},{"key":"77443_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04655-6","volume":"13","author":"P Liu","year":"2022","unstructured":"Liu, P. et al. Elevated nuclear localization of glycolytic enzyme TPI1 promotes lung adenocarcinoma and enhances chemoresistance. Cell Death Dis. 13, 205 (2022).","journal-title":"Cell Death Dis."},{"key":"77443_CR60","doi-asserted-by":"publisher","first-page":"16831","DOI":"10.1074\/jbc.RA119.010371","volume":"294","author":"MF Newhardt","year":"2019","unstructured":"Newhardt, M. F. et al. Enhancing cardiac glycolysis causes an increase in PDK4 content in response to short-term high-fat diet. J. Biol. Chem. 294, 16831\u201316845 (2019).","journal-title":"J. Biol. Chem."},{"key":"77443_CR61","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.thromres.2011.03.025","volume":"128","author":"B Pamukcu","year":"2011","unstructured":"Pamukcu, B., Lip, G. Y. & Shantsila, E. The nuclear factor-kappa B pathway in atherosclerosis: a potential therapeutic target for atherothrombotic vascular disease. Thromb. Res. 128, 117\u2013123 (2011).","journal-title":"Thromb. Res."},{"key":"77443_CR62","doi-asserted-by":"crossref","unstructured":"Mukhopadhyay, S. et al. Loss of IL-10 signaling in macrophages limits bacterial killing driven by prostaglandin E2. J. Exp. Med. 217, e20180649 (2020).","DOI":"10.1084\/jem.20180649"},{"key":"77443_CR63","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1161\/CIRCRESAHA.112.277525","volume":"111","author":"EK Koltsova","year":"2012","unstructured":"Koltsova, E. K. et al. Interleukin-27 receptor limits atherosclerosis in Ldlr\u2212\/\u2212 mice. Circ. Res. 111, 1274\u20131285 (2012).","journal-title":"Circ. Res."},{"key":"77443_CR64","doi-asserted-by":"publisher","first-page":"745061","DOI":"10.3389\/fphar.2021.745061","volume":"12","author":"JH Su","year":"2021","unstructured":"Su, J. H. et al. Interleukin-6: a novel target for cardio-cerebrovascular diseases. Front. Pharm. 12, 745061 (2021).","journal-title":"Front. Pharm."},{"key":"77443_CR65","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.cyto.2014.11.018","volume":"71","author":"RT Robinson","year":"2015","unstructured":"Robinson, R. T. IL12Rbeta1: the cytokine receptor that we used to know. Cytokine 71, 348\u2013359 (2015).","journal-title":"Cytokine"},{"key":"77443_CR66","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1182\/blood-2005-05-2034","volume":"106","author":"I Airoldi","year":"2005","unstructured":"Airoldi, I. et al. Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy. Blood 106, 3846\u20133853 (2005).","journal-title":"Blood"},{"key":"77443_CR67","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s11658-022-00372-2","volume":"27","author":"M Zhang","year":"2022","unstructured":"Zhang, M. et al. circ_0086296 induced atherosclerotic lesions via the IFIT1\/STAT1 feedback loop by sponging miR-576-3p. Cell Mol. Biol. Lett. 27, 80 (2022).","journal-title":"Cell Mol. Biol. Lett."},{"key":"77443_CR68","doi-asserted-by":"publisher","first-page":"821940","DOI":"10.1155\/2010\/821940","volume":"2010","author":"JY Kim","year":"2010","unstructured":"Kim, J. Y., Kim, H., Suk, K. & Lee, W. H. Activation of CD147 with cyclophilin A induces the expression of IFITM1 through ERK and PI3K in THP-1 cells. Mediat. Inflamm. 2010, 821940 (2010).","journal-title":"Mediat. Inflamm."},{"key":"77443_CR69","doi-asserted-by":"publisher","first-page":"e1000036","DOI":"10.1371\/journal.pgen.1000036","volume":"4","author":"J Skogsberg","year":"2008","unstructured":"Skogsberg, J. et al. Transcriptional profiling uncovers a network of cholesterol-responsive atherosclerosis target genes. PLoS Genet. 4, e1000036 (2008).","journal-title":"PLoS Genet."},{"key":"77443_CR70","doi-asserted-by":"publisher","first-page":"586","DOI":"10.5551\/jat.ED152","volume":"28","author":"Y Arai","year":"2021","unstructured":"Arai, Y. G6PD deficiency: a possible cardiovascular risk factor in older people. J. Atheroscler. Thromb. 28, 586\u2013587 (2021).","journal-title":"J. Atheroscler. Thromb."},{"key":"77443_CR71","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/nar\/gku1342","volume":"43","author":"A Bravard","year":"2015","unstructured":"Bravard, A. et al. The prion protein is critical for DNA repair and cell survival after genotoxic stress. Nucleic Acids Res. 43, 904\u2013916 (2015).","journal-title":"Nucleic Acids Res."},{"key":"77443_CR72","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1152\/physiolgenomics.00041.2017","volume":"50","author":"QM Chen","year":"2018","unstructured":"Chen, Q. M. & Maltagliati, A. J. Nrf2 at the heart of oxidative stress and cardiac protection. Physiol. Genom. 50, 77\u201397 (2018).","journal-title":"Physiol. Genom."},{"key":"77443_CR73","doi-asserted-by":"crossref","unstructured":"Kishimoto, Y., Kondo, K. & Momiyama, Y. The protective role of heme oxygenase\u22121 in atherosclerotic diseases. Int. J. Mol. Sci. 20, 3628 (2019).","DOI":"10.3390\/ijms20153628"},{"key":"77443_CR74","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1161\/01.CIR.97.19.1930","volume":"97","author":"D Lapenna","year":"1998","unstructured":"Lapenna, D. et al. Glutathione-related antioxidant defenses in human atherosclerotic plaques. Circulation 97, 1930\u20131934 (1998).","journal-title":"Circulation"},{"key":"77443_CR75","doi-asserted-by":"publisher","first-page":"808162","DOI":"10.3389\/fmolb.2022.808162","volume":"9","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. 6-shogaol inhibits oxidative stress-induced rat vascular smooth muscle cell apoptosis by regulating OXR1-p53 axis. Front. Mol. Biosci. 9, 808162 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"77443_CR76","doi-asserted-by":"publisher","first-page":"102313","DOI":"10.1016\/j.redox.2022.102313","volume":"52","author":"O Rom","year":"2022","unstructured":"Rom, O. et al. Induction of glutathione biosynthesis by glycine-based treatment mitigates atherosclerosis. Redox Biol. 52, 102313 (2022).","journal-title":"Redox Biol."},{"key":"77443_CR77","doi-asserted-by":"crossref","unstructured":"Ryter, S. W. Heme oxygenase-1: an anti-inflammatory effector in cardiovascular, lung, and related metabolic disorders. Antioxidants 11, 555 (2022).","DOI":"10.3390\/antiox11030555"},{"key":"77443_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05645-y","volume":"14","author":"M Tan","year":"2023","unstructured":"Tan, M. et al. Glutathione system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis. Cell Death Dis. 14, 131 (2023).","journal-title":"Cell Death Dis."},{"key":"77443_CR79","doi-asserted-by":"publisher","first-page":"144","DOI":"10.14503\/THIJ-16-6052","volume":"45","author":"JE Thomas","year":"2018","unstructured":"Thomas, J. E. et al. Glucose-6-phosphate dehydrogenase deficiency is associated with cardiovascular disease in U.S. military centers. Tex. Heart Inst. J. 45, 144\u2013150 (2018).","journal-title":"Tex. Heart Inst. J."},{"key":"77443_CR80","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/0300060513477004","volume":"41","author":"X Xu","year":"2013","unstructured":"Xu, X., Luo, P., Wang, Y., Cui, Y. & Miao, L. Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) is a novel therapeutic target for diabetic complications. J. Int. Med. Res. 41, 13\u201319 (2013).","journal-title":"J. Int. Med. Res."},{"key":"77443_CR81","doi-asserted-by":"publisher","first-page":"101950","DOI":"10.1016\/j.redox.2021.101950","volume":"41","author":"D Ross","year":"2021","unstructured":"Ross, D. & Siegel, D. The diverse functionality of NQO1 and its roles in redox control. Redox Biol. 41, 101950 (2021).","journal-title":"Redox Biol."},{"key":"77443_CR82","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.18632\/aging.100988","volume":"8","author":"A Smirnov","year":"2016","unstructured":"Smirnov, A. et al. FOXM1 regulates proliferation, senescence and oxidative stress in keratinocytes and cancer cells. Aging 8, 1384\u20131397 (2016).","journal-title":"Aging"},{"key":"77443_CR83","doi-asserted-by":"crossref","unstructured":"Yu, R. et al. Associations between circulating SELENOP level and disorders of glucose and lipid metabolism: a meta-analysis. Antioxidants 11, 1263 (2022).","DOI":"10.3390\/antiox11071263"},{"key":"77443_CR84","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/j.1875-9114.1983.tb03277.x","volume":"3","author":"DE Furst","year":"1983","unstructured":"Furst, D. E. Mechanism of action, pharmacology, clinical efficacy and side effects of auranofin. An orally administered organic gold compound for the treatment of rheumatoid arthritis. Pharmacotherapy 3, 284\u2013298 (1983).","journal-title":"Pharmacotherapy"},{"key":"77443_CR85","doi-asserted-by":"publisher","first-page":"108272","DOI":"10.1016\/j.intimp.2021.108272","volume":"101","author":"M Yamashita","year":"2021","unstructured":"Yamashita, M. Auranofin: past to present, and repurposing. Int. Immunopharmacol. 101, 108272 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"77443_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-03062-8","volume":"7","author":"N Verweij","year":"2017","unstructured":"Verweij, N., Eppinga, R. N., Hagemeijer, Y. & van der Harst, P. Identification of 15 novel risk loci for coronary artery disease and genetic risk of recurrent events, atrial fibrillation and heart failure. Sci. Rep. 7, 2761 (2017).","journal-title":"Sci. Rep."},{"key":"77443_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-37027-x","volume":"13","author":"W Dong","year":"2023","unstructured":"Dong, W., Gong, Y., Yang, B. & Li, B. Bioinformatics analysis and reveal potential crosstalk genetic and immune relationships between atherosclerosis and periodontitis. Sci. Rep. 13, 10381 (2023).","journal-title":"Sci. Rep."},{"key":"77443_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36614-w","volume":"14","author":"Y Wei","year":"2023","unstructured":"Wei, Y. et al. GSDME-mediated pyroptosis promotes the progression and associated inflammation of atherosclerosis. Nat. Commun. 14, 929 (2023).","journal-title":"Nat. Commun."},{"key":"77443_CR89","doi-asserted-by":"publisher","first-page":"891916","DOI":"10.3389\/fmed.2022.891916","volume":"9","author":"DM Potashnikova","year":"2022","unstructured":"Potashnikova, D. M. et al. CTLs from patients with atherosclerosis show elevated adhesiveness and distinct integrin expression patterns on 2D substrates. Front. Med. 9, 891916 (2022).","journal-title":"Front. Med."},{"key":"77443_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-47257-8","volume":"13","author":"H Ji","year":"2023","unstructured":"Ji, H. et al. Bioinformatics analysis of immune cell infiltration patterns and potential diagnostic markers in atherosclerosis. Sci. Rep. 13, 19821 (2023).","journal-title":"Sci. Rep."},{"key":"77443_CR91","doi-asserted-by":"crossref","unstructured":"Alloza, I. et al. BIRC6 is associated with vulnerability of carotid atherosclerotic plaque. Int. J. Mol. Sci. 21, 9387 (2020).","DOI":"10.3390\/ijms21249387"},{"key":"77443_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40537-x","volume":"14","author":"W Yan","year":"2023","unstructured":"Yan, W. et al. Auranofin targets UBA1 and enhances UBA1 activity by facilitating ubiquitin trans-thioesterification to E2 ubiquitin-conjugating enzymes. Nat. Commun. 14, 4798 (2023).","journal-title":"Nat. Commun."},{"key":"77443_CR93","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.semcdb.2011.12.006","volume":"23","author":"EK Fredrickson","year":"2012","unstructured":"Fredrickson, E. K. & Gardner, R. G. Selective destruction of abnormal proteins by ubiquitin-mediated protein quality control degradation. Semin. Cell Dev. Biol. 23, 530\u2013537 (2012).","journal-title":"Semin. Cell Dev. Biol."},{"key":"77443_CR94","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/cvr\/cvp333","volume":"85","author":"J Herrmann","year":"2010","unstructured":"Herrmann, J., Lerman, L. O. & Lerman, A. On to the road to degradation: atherosclerosis and the proteasome. Cardiovasc. Res. 85, 291\u2013302 (2010).","journal-title":"Cardiovasc. Res."},{"key":"77443_CR95","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1111\/j.1460-9568.2006.04748.x","volume":"23","author":"SW Ko","year":"2006","unstructured":"Ko, S. W. et al. Evidence for a role of CaMKIV in the development of opioid analgesic tolerance. Eur. J. Neurosci. 23, 2158\u20132168 (2006).","journal-title":"Eur. J. Neurosci."},{"key":"77443_CR96","doi-asserted-by":"publisher","first-page":"e108240","DOI":"10.1371\/journal.pone.0108240","volume":"9","author":"P Moustardas","year":"2014","unstructured":"Moustardas, P. et al. The complementary effects of atorvastatin and exercise treatment on the composition and stability of the atherosclerotic plaques in ApoE knockout mice. PLoS ONE 9, e108240 (2014).","journal-title":"PLoS ONE"},{"key":"77443_CR97","doi-asserted-by":"publisher","first-page":"e97009","DOI":"10.1371\/journal.pone.0097009","volume":"9","author":"P Nie","year":"2014","unstructured":"Nie, P. et al. Atorvastatin improves plaque stability in ApoE-knockout mice by regulating chemokines and chemokine receptors. PLoS ONE 9, e97009 (2014).","journal-title":"PLoS ONE"},{"key":"77443_CR98","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1161\/01.ATV.0000036081.01231.16","volume":"22","author":"F Bea","year":"2002","unstructured":"Bea, F. et al. Simvastatin promotes atherosclerotic plaque stability in apoE-deficient mice independently of lipid lowering. Arterioscler Thromb. Vasc. Biol. 22, 1832\u20131837 (2002).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"77443_CR99","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1161\/ATVBAHA.107.142570","volume":"27","author":"S Zadelaar","year":"2007","unstructured":"Zadelaar, S. et al. Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler Thromb. Vasc. Biol. 27, 1706\u20131721 (2007).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"77443_CR100","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fcvm.2019.00046","volume":"6","author":"S Oppi","year":"2019","unstructured":"Oppi, S., Luscher, T. F. & Stein, S. Mouse models for atherosclerosis research-which is my line? Front. Cardiovasc. Med. 6, 46 (2019).","journal-title":"Front. Cardiovasc. Med."},{"key":"77443_CR101","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.cmet.2022.09.019","volume":"34","author":"AR Cox","year":"2022","unstructured":"Cox, A. R. et al. The rheumatoid arthritis drug auranofin lowers leptin levels and exerts antidiabetic effects in obese mice. Cell Metab. 34, 1932\u20131946 e1937 (2022).","journal-title":"Cell Metab."},{"key":"77443_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2021.08.010","volume":"334","author":"B Dolfi","year":"2021","unstructured":"Dolfi, B., Gallerand, A., Haschemi, A., Guinamard, R. R. & Ivanov, S. Macrophage metabolic regulation in atherosclerotic plaque. Atherosclerosis 334, 1\u20138 (2021).","journal-title":"Atherosclerosis"},{"key":"77443_CR103","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.atherosclerosis.2019.10.002","volume":"291","author":"L Menegaut","year":"2019","unstructured":"Menegaut, L., Jalil, A., Thomas, C. & Masson, D. Macrophage fatty acid metabolism and atherosclerosis: the rise of PUFAs. Atherosclerosis 291, 52\u201361 (2019).","journal-title":"Atherosclerosis"},{"key":"77443_CR104","doi-asserted-by":"publisher","first-page":"116092","DOI":"10.1016\/j.biopha.2023.116092","volume":"170","author":"S Xiao","year":"2024","unstructured":"Xiao, S. et al. Macrophage fatty acid oxidation in atherosclerosis. Biomed. Pharmacother. 170, 116092 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"77443_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-09590-2","volume":"12","author":"YC Toner","year":"2022","unstructured":"Toner, Y. C. et al. Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation. Sci. Rep. 12, 6185 (2022).","journal-title":"Sci. Rep."},{"key":"77443_CR106","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.jacc.2006.05.076","volume":"48","author":"A Tawakol","year":"2006","unstructured":"Tawakol, A. et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J. Am. Coll. Cardiol. 48, 1818\u20131824 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"77443_CR107","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.jacc.2007.05.024","volume":"50","author":"JH Rudd","year":"2007","unstructured":"Rudd, J. H. et al. 18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J. Am. Coll. Cardiol. 50, 892\u2013896 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"key":"77443_CR108","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.jcmg.2010.09.017","volume":"3","author":"C Giannarelli","year":"2010","unstructured":"Giannarelli, C. et al. Contrast-enhanced ultrasound imaging detects intraplaque neovascularization in an experimental model of atherosclerosis. JACC Cardiovasc. Imaging 3, 1256\u20131264 (2010).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"77443_CR109","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/eurheartj\/ehr136","volume":"33","author":"C Giannarelli","year":"2012","unstructured":"Giannarelli, C. et al. Synergistic effect of liver X receptor activation and simvastatin on plaque regression and stabilization: an magnetic resonance imaging study in a model of advanced atherosclerosis. Eur. Heart J. 33, 264\u2013273 (2012).","journal-title":"Eur. Heart J."},{"key":"77443_CR110","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1002\/nbm.3369","volume":"28","author":"C Calcagno","year":"2015","unstructured":"Calcagno, C. et al. Three-dimensional dynamic contrast-enhanced MRI for the accurate, extensive quantification of microvascular permeability in atherosclerotic plaques. NMR Biomed. 28, 1304\u20131314 (2015).","journal-title":"NMR Biomed."},{"key":"77443_CR111","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.jcmg.2011.07.008","volume":"4","author":"J Bucerius","year":"2011","unstructured":"Bucerius, J. et al. Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study. JACC Cardiovasc. Imaging 4, 1195\u20131205 (2011).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"77443_CR112","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jcmg.2011.11.025","volume":"5","author":"E Vucic","year":"2012","unstructured":"Vucic, E. et al. Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin. JACC Cardiovasc. Imaging 5, 819\u2013828 (2012).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"77443_CR113","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.jcmg.2011.04.020","volume":"4","author":"E Vucic","year":"2011","unstructured":"Vucic, E. et al. Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging. JACC Cardiovasc. Imaging 4, 1100\u20131109 (2011).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"77443_CR114","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/jn\/138.3.515","volume":"138","author":"XJ Zhang","year":"2008","unstructured":"Zhang, X. J., Chinkes, D. L., Aarsland, A., Herndon, D. N. & Wolfe, R. R. Lipid metabolism in diet-induced obese rabbits is similar to that of obese humans. J. Nutr. 138, 515\u2013518 (2008).","journal-title":"J. Nutr."},{"key":"77443_CR115","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/NAQ.0000000000000118","volume":"39","author":"LE Price","year":"2015","unstructured":"Price, L. E., Shea, K. & Gephart, S. The Veterans Affairs\u2019 corporate data warehouse: uses and implications for nursing research and practice. Nurs. Adm. Q 39, 311\u2013318 (2015).","journal-title":"Nurs. Adm. Q"},{"key":"77443_CR116","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/rheumatology\/36.5.560","volume":"36","author":"WF Kean","year":"1997","unstructured":"Kean, W. F., Hart, L. & Buchanan, W. W. Auranofin. Br. J. Rheumatol. 36, 560\u2013572 (1997).","journal-title":"Br. J. Rheumatol."},{"key":"77443_CR117","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40268-015-0083-y","volume":"15","author":"C Roder","year":"2015","unstructured":"Roder, C. & Thomson, M. J. Auranofin: repurposing an old drug for a golden new age. Drugs R. D. 15, 13\u201320 (2015).","journal-title":"Drugs R. D."},{"key":"77443_CR118","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/0002-9343(83)90481-3","volume":"75","author":"DT Walz","year":"1983","unstructured":"Walz, D. T., DiMartino, M. J., Griswold, D. E., Intoccia, A. P. & Flanagan, T. L. Biologic actions and pharmacokinetic studies of auranofin. Am. J. Med. 75, 90\u2013108 (1983).","journal-title":"Am. J. Med."},{"key":"77443_CR119","first-page":"117","volume":"10","author":"DT Walz","year":"1983","unstructured":"Walz, D. T., Griswold, D. E., DiMartino, M. J. & Bumbier, E. E. Distribution of gold in rat blood after intravenous administration of auranofin, gold sodium thiomalate and aurothioglucose to rats. J. Rheumatol. 10, 117\u2013120 (1983).","journal-title":"J. Rheumatol."},{"key":"77443_CR120","first-page":"279","volume":"41","author":"L Messori","year":"2004","unstructured":"Messori, L. & Marcon, G. Gold complexes in the treatment of rheumatoid arthritis. Met Ions Biol. Syst. 41, 279\u2013304 (2004).","journal-title":"Met Ions Biol. Syst."},{"key":"77443_CR121","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00296-018-4041-1","volume":"38","author":"S Nikfar","year":"2018","unstructured":"Nikfar, S., Saiyarsarai, P., Tigabu, B. M. & Abdollahi, M. Efficacy and safety of interleukin-1 antagonists in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatol. Int. 38, 1363\u20131383 (2018).","journal-title":"Rheumatol. Int."},{"key":"77443_CR122","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.semarthrit.2007.02.001","volume":"37","author":"SM Proudman","year":"2007","unstructured":"Proudman, S. M. et al. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. Semin Arthritis Rheum. 37, 99\u2013111 (2007).","journal-title":"Semin Arthritis Rheum."},{"key":"77443_CR123","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1177\/0091270005277938","volume":"45","author":"T Doan","year":"2005","unstructured":"Doan, T. & Massarotti, E. Rheumatoid arthritis: an overview of new and emerging therapies. J. Clin. Pharm. 45, 751\u2013762 (2005).","journal-title":"J. Clin. Pharm."},{"key":"77443_CR124","doi-asserted-by":"crossref","unstructured":"Capparelli, E. V., Bricker-Ford, R., Rogers, M. J., McKerrow, J. H. & Reed, S. L. Phase I clinical trial results of auranofin, a novel antiparasitic agent. Antimicrob Agents Chemother. 61, e01947\u201316 (2017).","DOI":"10.1128\/AAC.01947-16"},{"key":"77443_CR125","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom, S. et al. Drug repurposing: progress, challenges and recommendations. Nat. Rev. Drug Discov. 18, 41\u201358 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"77443_CR126","doi-asserted-by":"publisher","first-page":"E37","DOI":"10.1002\/ijc.27779","volume":"132","author":"Y Wu","year":"2013","unstructured":"Wu, Y. et al. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography\/computed tomography for the detection of metastases in non-small-cell lung cancer patients. Int. J. Cancer 132, E37\u2013E47 (2013).","journal-title":"Int. J. Cancer"},{"key":"77443_CR127","first-page":"757","volume":"62","author":"K Ishii","year":"2010","unstructured":"Ishii, K. Amyloid PET in Alzheimer research. Brain Nerve 62, 757\u2013767 (2010).","journal-title":"Brain Nerve"},{"key":"77443_CR128","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.jacc.2006.03.069","volume":"48","author":"N Tahara","year":"2006","unstructured":"Tahara, N. et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J. Am. Coll. Cardiol. 48, 1825\u20131831 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"77443_CR129","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.jacc.2013.04.066","volume":"62","author":"A Tawakol","year":"2013","unstructured":"Tawakol, A. et al. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography\/computed tomography feasibility study. J. Am. Coll. Cardiol. 62, 909\u2013917 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"77443_CR130","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/B978-0-12-391860-4.00011-2","volume":"508","author":"ME Lobatto","year":"2012","unstructured":"Lobatto, M. E. et al. Imaging the efficacy of anti-inflammatory liposomes in a rabbit model of atherosclerosis by non-invasive imaging. Methods Enzymol. 508, 211\u2013228 (2012).","journal-title":"Methods Enzymol."},{"key":"77443_CR131","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.nuclcard.2005.03.002","volume":"12","author":"A Tawakol","year":"2005","unstructured":"Tawakol, A. et al. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J. Nucl. Cardiol. 12, 294\u2013301 (2005).","journal-title":"J. Nucl. Cardiol."},{"key":"77443_CR132","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.2967\/jnumed.109.065151","volume":"50","author":"A Rominger","year":"2009","unstructured":"Rominger, A. et al. 18F-FDG PET\/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease. J. Nucl. Med. 50, 1611\u20131620 (2009).","journal-title":"J. Nucl. Med."},{"key":"77443_CR133","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.nuclcard.2007.10.009","volume":"15","author":"B Paulmier","year":"2008","unstructured":"Paulmier, B. et al. Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events. J. Nucl. Cardiol. 15, 209\u2013217 (2008).","journal-title":"J. Nucl. Cardiol."},{"key":"77443_CR134","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2385-6-3","volume":"6","author":"Z Zhang","year":"2006","unstructured":"Zhang, Z. et al. Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation. BMC Nucl. Med. 6, 3 (2006).","journal-title":"BMC Nucl. Med."},{"key":"77443_CR135","doi-asserted-by":"publisher","first-page":"100380","DOI":"10.1016\/j.ajpc.2022.100380","volume":"12","author":"A Aronov","year":"2022","unstructured":"Aronov, A., Kim, Y. J., Sweiss, N. J. & Nazir, N. T. Cardiovascular disease risk evaluation impact in patients with rheumatoid arthritis. Am. J. Prev. Cardiol. 12, 100380 (2022).","journal-title":"Am. J. Prev. Cardiol."},{"key":"77443_CR136","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/alz.12465","volume":"18","author":"C Zheng","year":"2022","unstructured":"Zheng, C. et al. Potential long-term effect of tumor necrosis factor inhibitors on dementia risk: a propensity score matched retrospective cohort study in US veterans. Alzheimers Dement 18, 1248\u20131259 (2022).","journal-title":"Alzheimers Dement"},{"key":"77443_CR137","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1002\/alz.13853","volume":"20","author":"J Ramos-Cejudo","year":"2024","unstructured":"Ramos-Cejudo, J. et al. Antidepressant exposure and long-term dementia risk in a nationwide retrospective study on US veterans with midlife major depressive disorder. Alzheimers Dement 20, 4106\u20134114 (2024).","journal-title":"Alzheimers Dement"},{"key":"77443_CR138","doi-asserted-by":"crossref","unstructured":"Allegra, S., Chiara, F., Di Grazia, D., Gaspari, M. & De Francia, S. Evaluation of sex differences in preclinical pharmacology research: How far is left to go? Pharmaceuticals 16, 786 (2023).","DOI":"10.3390\/ph16060786"},{"key":"77443_CR139","doi-asserted-by":"publisher","first-page":"eadn3510","DOI":"10.1126\/sciadv.adn3510","volume":"10","author":"AK McClain","year":"2024","unstructured":"McClain, A. K., Monteleone, P. P. & Zoldan, J. Sex in cardiovascular disease: Why this biological variable should be considered in in vitro models. Sci. Adv. 10, eadn3510 (2024).","journal-title":"Sci. Adv."},{"key":"77443_CR140","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13293-025-00714-7","volume":"16","author":"L McClements","year":"2025","unstructured":"McClements, L., Kautzky-Willer, A., Kararigas, G., Ahmed, S. B. & Stallone, J. N. The role of sex differences in cardiovascular, metabolic, and immune functions in health and disease: a review for \u201cSex Differences in Health Awareness Day. Biol. Sex. Differ. 16, 33 (2025).","journal-title":"Biol. Sex. Differ."},{"key":"77443_CR141","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1161\/CIRCULATIONAHA.116.026668","volume":"135","author":"FD Ramirez","year":"2017","unstructured":"Ramirez, F. D. et al. Sex bias is increasingly prevalent in preclinical cardiovascular research: implications for translational medicine and health equity for women: a systematic assessment of leading cardiovascular journals over a 10-year period. Circulation 135, 625\u2013626 (2017).","journal-title":"Circulation"},{"key":"77443_CR142","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41586-019-0948-2","volume":"566","author":"CS McAlpine","year":"2019","unstructured":"McAlpine, C. S. et al. Sleep modulates haematopoiesis and protects against atherosclerosis. Nature 566, 383\u2013387 (2019).","journal-title":"Nature"},{"key":"77443_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4065","volume":"5","author":"R Duivenvoorden","year":"2014","unstructured":"Duivenvoorden, R. et al. A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation. Nat. Commun. 5, 3065 (2014).","journal-title":"Nat. Commun."},{"key":"77443_CR144","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/biostatistics\/kxw030","volume":"18","author":"Y Benjamini","year":"2017","unstructured":"Benjamini, Y. & Cohen, R. Weighted false discovery rate controlling procedures for clinical trials. Biostatistics 18, 91\u2013104 (2017).","journal-title":"Biostatistics"},{"key":"77443_CR145","first-page":"1530","volume":"42","author":"S Tsuchiya","year":"1982","unstructured":"Tsuchiya, S. et al. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 42, 1530\u20131536 (1982).","journal-title":"Cancer Res."},{"key":"77443_CR146","first-page":"328","volume":"170","author":"RB Dessau","year":"2008","unstructured":"Dessau, R. B. & Pipper, C. B. [\u201cR\u201d-project for statistical computing]. Ugeskr. Laege. 170, 328\u2013330 (2008).","journal-title":"Ugeskr. Laege."},{"key":"77443_CR147","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"77443_CR148","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"77443_CR149","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"77443_CR150","doi-asserted-by":"publisher","unstructured":"Sayols, S. rrvgo: a Bioconductor package for interpreting lists of Gene Ontology terms. MicroPubl Biol. 2023 https:\/\/doi.org\/10.17912\/micropub.biology.000811 (2023).","DOI":"10.17912\/micropub.biology.000811"},{"key":"77443_CR151","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1021\/nn506750r","volume":"9","author":"ME Lobatto","year":"2015","unstructured":"Lobatto, M. E. et al. Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging. ACS Nano 9, 1837\u20131847 (2015).","journal-title":"ACS Nano"},{"key":"77443_CR152","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1021\/mp100309y","volume":"7","author":"ME Lobatto","year":"2010","unstructured":"Lobatto, M. E. et al. Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis. Mol. Pharm. 7, 2020\u20132029 (2010).","journal-title":"Mol. Pharm."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77443-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77443-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77443-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:02:02Z","timestamp":1790938922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77443-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":152,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77443"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77443-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.L.M.B. is the founder and former CEO of Clinical Gene Networks (CGN), a privately-held company that seeks to commercialize clinical gene networks underlying coronary artery disease, myocardial infarction, and stroke. Dr. Bjorkegren serves as Chairman of the Board, and owns equity in the company. Dr. Bjorkegren also receives financial compensation as a consultant for CGN. CG reports consulting fees from Novartis. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10435"}}